Treace Medical Concepts, Inc.

NASDAQ:TMCI

Medical - Devices

Healthcare
$4.53 +1.87%

+$0.08 today

Market cap
$296.98M
Beta
1.41
P/E (TTM)
-4.3
EPS (TTM)
-$0.95
52W Low $1.17High $7.78

Volume 0.18M

Average 0.73M

TMCI Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Treace Medical Concepts, Inc.NASDAQ: TMCI

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 64.59M shares rose 3.1% year over year, ahead of the +2.3% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 1.1% from the prior quarter. Over 3 fiscal years it compounded at +4.6% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +3.1% holds above the trailing-twelve-month pace of +2.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
64.59M+1.1% QoQ
Last fiscal yearDec 2025
63.27M+1.9% YoY
LTMMar 2026
63.74M+2.3% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.1%——
1 year+1.9%——
3-year CAGR+4.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
63.27M USD
Year-over-year change
+1.9%
4-year CAGR
+4.0%

Weighted Avg Shares vs competitors

How TMCI compares with its peers on the latest reported figures

  • TMCI's LTM Mar 2026 weighted avg shares of 63.74M shares is the 5th highest of the 8 companies compared; the peer median is 64.73M shares.
  • Its year-over-year change of +2.3% is the 7th highest of 8, against a peer median of +3.0%.
  • Over three fiscal years its annual growth of +4.6% compares with a peer median of +14.2%.
TMCI Competitors Peer median
Weighted Avg Shares for TMCI and competitors
Company Period LTM YoY 3-year CAGR
TOIThe Oncology Institute, Inc.LTM Mar 2026984.84M +1200.0%+133.3%
LABStandard BioTools Inc.LTM Mar 2026384.09M +2.7%+69.5%
BVSBioventus Inc.LTM Mar 202666.84M +2.5%+2.8%
EOLSEvolus, Inc.LTM Mar 202664.73M +3.0%+4.8%
TMCITreace Medical Concepts, Inc.LTM Mar 202663.74M +2.3%+4.6%
RXSTRxSight, Inc.LTM Mar 202641.05M +3.2%+14.2%
CBLLCeriBell, Inc.LTM Mar 202637M +38.8%+16.1%
KIDSOrthoPediatrics Corp.LTM Mar 202623.51M +1.4%+4.3%
Peer median (excluding TMCI) 64.73M+3.0%+14.2%

Competitors are the stored peer set for TMCI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue94.42M141.84M187.12M209.36M212.69M
Cost of Revenue16.89M27.52M35.18M41.09M42.94M
Gross Profit77.53M114.32M151.94M168.26M169.75M
Gross Margin82.1%80.6%81.2%80.4%79.8%
Research & Development10.2M13.58M15.44M20.59M20.28M
Selling, General & Admin83.84M137.57M187.93M203.36M203.62M
Operating Expenses94.04M149.16M203.37M223.95M223.91M
Depreciation & Amortization685K2.13M5.35M8.42M10.5M
EBITDA(15.81M)(36.28M)(39.01M)(42.07M)(43.18M)
EBITDA Margin-16.7%-25.6%-20.8%-20.1%-20.3%
Operating Income(16.51M)(34.84M)(51.43M)(55.69M)(54.15M)
Operating Margin-17.5%-24.6%-27.5%-26.6%-25.5%
Interest Income18K1.31M6.73M4.88M2.78M
Interest Expense4.06M4.4M5.17M5.26M5.32M
Other Income / Expenses(4.04M)(7.97M)1.9M(55K)(4.85M)
Income Before Tax(20.55M)(42.82M)(49.53M)(55.74M)(59M)
Pre-Tax Margin-21.8%-30.2%-26.5%-26.6%-27.7%
Income Tax Expense00000
Net Income(20.55M)(42.82M)(49.53M)(55.74M)(59M)
Net Margin-21.8%-30.2%-26.5%-26.6%-27.7%
EPS (Basic)(0.38)(0.77)(0.81)(0.90)(0.93)
EPS (Diluted)(0.38)(0.77)(0.81)(0.90)(0.93)
Weighted Avg Shares54.18M55.28M60.85M62.11M63.27M
Weighted Avg Shares (Diluted)54.18M55.28M60.85M62.11M63.27M

Treace Medical Concepts, Inc.

NASDAQ:TMCI

Intrinsic Alpha fair value

Locked

Current Price

$4.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.